RenatoV.IozzoMD
Pathology • Philadelphia, PAAnatomic Pathology, Clinical Pathology
Professor, Pathology, Anatomy and Cell Biology, Jefferson Medical College-Thos Jefferson Univ
Dr. Iozzo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
132 S 10th St
285k
Philadelphia, PA 19107Phone+1 215-503-4817Fax+1 215-503-4817
Education & Training
University of WashingtonResidency, Pathology-Anatomic and Clinical, 1978 - 1979
University of Florence Faculty of MedicineClass of 1975
Certifications & Licensure
PA State Medical License 1982 - 2026
WA State Medical License 1979 - 2008
American Board of Pathology Anatomic Pathology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Publications & Presentations
PubMed
- Comprehensive investigation of proteoglycan gene expression in breast cancer: Discovery of a unique proteoglycan gene signature linked to the malignant phenotype.Simone Buraschi, Gabriel Pascal, Federico Liberatore, Renato V Iozzo
Proteoglycan Research. 2025-01-08 - Pivotal roles of biglycan and decorin in regulating bone mass, water retention, and bone toughness.Rui Hua, Yan Han, Qingwen Ni, Roberto J Fajardo, Renato V Iozzo
Bone Research. 2025-01-02 - Correction: Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatin.Simone Buraschi, Shi-Qiong Xu, Manuela Stefanello, Igor Moskalev, Alaide Morcavallo
Oncotarget. 2024-10-01
Press Mentions
Tissue Around Tumor Holds Key to Fighting Triple Negative Breast CancerSeptember 19th, 2012
Protein in Blood Exerts Natural Anti-Cancer ProtectionFebruary 10th, 2016
Post Doc Fellow – Pathology – Full TimeMarch 5th, 2016
Grant Support
- Mitostatin-evoked mitophagy for breast cancer inhibitionTHOMAS JEFFERSON UNIVERSITY2023–2025
- Proteoglycan regulation of tumor angiogenesis and endothelial cell autophagyTHOMAS JEFFERSON UNIVERSITY2020–2025
- Proteoglycan regulation of tumor angiogenesis and endothelial cell autophagyTHOMAS JEFFERSON UNIVERSITY2020–2025
- Altered Proteoglycan Gene Expression And CancerNational Cancer Institute1993–2012
- The Biology Of Perlecan In Cancer And AngiogenesisNational Cancer Institute2007–2011
- Natural EGFR Antagonists And CancerNational Cancer Institute2007–2010
- Biology Of Perlecan In CancerNational Cancer Institute2001–2006
- Biology Of Perlecan In Cancer And DevelopmentNational Cancer Institute1996–2000
- Heparan Sulfate And TransformationNational Cancer Institute1990–1994
- Neoplastic Modulation Of Proteoglycan MetabolismNational Cancer Institute1988–1992
- Proteoglycans And Aging Vascular CellsNational Institute On Aging1988–1989
- Proteoglycans And Aging Vascular CellsNational Institute On Aging1987–1988
- Neoplastic Modulation Of Proteoglycan MetabolismNational Cancer Institute1985–1987
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
